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Abstract
We investigated the cytogenetic and gene expression responses of peripheral blood cells of
non-human primates (NHP, Macaca mulatta) that were whole-thorax irradiated with a single
dose of 10 Gy. In this model, partial irradiation of NHPs in the thoracic region (Whole Thorax
Lung Irradiation, WTLI) allows the study of late radiation-induced lung injury, while avoiding
acute radiation syndromes related to hematopoietic and gastrointestinal injury. A transient
drop in circulating lymphocytes and platelets was seen by 9 days, followed by elevations in
respiratory rate, circulating neutrophils, lymphocytes, and monocytes at 60–100 days, cor-
responding to computed tomography (CT) and histologic evidence of pneumonitis, and elec-
tive euthanasia of four animals. To evaluate long-term DNA damage in NHP peripheral
blood lymphocytes after 10 Gy WTLI, we used the cytokinesis-block micronucleus (CBMN)
assay to measure chromosomal aberrations as post-mitotic micronuclei in blood samples
collected up to 8 months after irradiation. Regression analysis showed significant induction
of micronuclei in NHP blood cells that persisted with a gradual decline over the 8-month
study period, suggesting long-term DNA damage in blood lymphocytes after WTLI.
We also report transcriptomic changes in blood up to 30 days after WTLI. We isolated
total RNA from peripheral blood at 3 days before and then at 2, 5 and 30 days after irradia-
tion. We identified 1187 transcripts that were significantly changed across the 30-day time
course. From changes in gene expression, we identified biological processes related to
immune responses, which persisted across the 30-day study. Response to oxygen-contain-
ing compounds and bacteria were implicated by gene-expression changes at the earliest
day 2 and latest, day 30 time-points. Gene expression changes suggest a persistent altered
state of the immune system, specifically response to infection, for at least a month after
WTLI.
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Introduction
The Non-Human Primate (NHP) is the most appropriate model for the study of radiation
response and injury, as well as for assessing the effect of mitigators of acute radiation syn-
drome (ARS) and lung Delayed Effects of Acute Radiation Exposure (DEARE) [1]. The NHP
model has advantages over small animal models, as it more closely resembles human physiol-
ogy, size and longevity; and studies of health effects of radiation exposure in NHPs address the
need for transferability of large-animal study results to humans [2]. NHPs mimic humans in
many ways including similarities in genome, neuroanatomy, neurophysiology, immunogenet-
ics, and age-related changes in immune function [3, 4]. NHPs also share similar hematopoietic
stem cell dynamics, engraftment properties, and cytokine requirements with humans [5, 6].
Studies of the genome of Macaca mulatta have revealed 93% sequence similarity between M.
mulatta and H. sapiens. Positive selection of genes in the human genome appear to be enriched
in biological functions related to immune response and signal transduction [7], making M.
mulatta a relevant NHP model for molecular studies and cytogenetic analyses [8].
Total body irradiation (TBI) studies in mice and NHPs have provided critical information
related to the changes associated with ARS, specifically tissue damage and organ failure in
addition to diagnostic endpoints such as blood cell counts and respiratory rates. In a highly
comprehensive and systematic review, MacVittie et al [9] provide a detailed comparison of fif-
teen independent studies of TBI of NHPs with and without medical management including
mitigation of hematopoietic effects. These studies have begun to establish dose-response rela-
tionships for induction of Hematopoietic ARS (H-ARS, 7.2–8.9 Gy) [10] and Gastro-Intestinal
ARS (GI-ARS, 10–14 Gy) [11] in NHP by total body irradiation. In another study, NHP were
exposed to TBI doses between 6.25 and 8.75 Gy to investigate H-ARS within the first 60 days
following TBI; neutropenia, lymphopenia and loss of platelets were observed to occur within 2
weeks after irradiation [12].
With the use of in vivo TBI studies in NHP and mouse models, a number of candidate
countermeasures have been developed to mitigate both hematopoietic and GI injury in acute
radiation syndrome (summarized in [13]). With the help of such mitigators, especially in a
more realistic nuclear or radiological event scenario where partial shielding may occur and
dose is non-uniform, there is an increased probability of surviving H-ARS and GI-ARS. This
in turn increases the probability of late development of multi-organ failure radiation sub-syn-
dromes such as cutaneous and lung injury [13, 14].
The lung is a particularly radiosensitive organ in humans. From radiation studies in
patients with metastatic cancer receiving upper partial-body irradiation, development of lung
injury in the form of pneumonitis occurred after an 8 Gy dose of radiation [14, 15]. The Medi-
cal Countermeasures against Radiological Threats (MCART) Consortium therefore estab-
lished an animal model platform in compliance with the FDA Animal Rule for testing medical
countermeasures for the treatment of ARS and prolonged effects of radiation including lung
DEARE [1, 16]. Both mouse and NHP models were established that comprise a more realistic
model of radiation response and its sequelae compared to Total Body Irradiation (TBI), and
these are called Partial Body Irradiated with Bone Marrow sparing (PBI/BM) models. A study
in the PBI/BM5 (Partial Body Irradiation with 5% bone marrow sparing) NHP model per-
formed by MacVittie et al. [17] has extensively characterized the radiation-induced lung and
gastro-intestinal damage in addition to changes in blood sub-populations. All doses of PBI/
BM5 caused neutropenia and thrombocytopenia with full recovery by 30 days and 60 days
post irradiation, respectively.
To address radiation-induced lung injury and mitigation, the Whole Thorax Lung Irradia-
tion (WTLI) model was established, in which a dose of radiation is targeted at the mid-point of
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the thorax, irradiating both lung and heart [14, 18]. Our study focused on WTLI of NHP and
long-term changes in peripheral blood at the cytogenetic and transcriptomic levels; and was
part of a larger study of a novel mitigator of lung injury. The mitigator study investigates the
role of a manganese porphyrin based mimic of superoxide dismutase, Mn (II) meso-tetrakis
(N-n-hexylpyridinium-2-yl) porphyrin, MnTnHex-2-PyP5+ [19]. Its analog, MnTnBuOE-
2-PyP5+ (BMX-001) is in two clinical trials on the radioprotection of normal tissue in glioma
and head & neck cancer patients (NCT02655601 and NCT02990468). In our arm of the study,
NHPs were exposed to a high-dose partial body exposure of 10 Gy x-rays, which is an LD70/180
(a lethal dose to 70% of the population in 180 days) in the NHP-WTLI model [14, 18]. All ani-
mals developed pneumonitis after WTLI irradiation at this dose.
The cytokinesis-blocked micronucleus assay (CBMN) is one of the most commonly used
and best-validated methods for measuring chromosome damage in peripheral blood lympho-
cytes [20, 21] and also one of the few available techniques with the required characteristics of
sensitivity, specificity, transportability, and reproducibility to be an effective biological dosime-
ter of ionizing radiation exposure [22]. The measurement of DNA damage in cultured human
and/or mammalian cells is specifically restricted to once-divided binucleate (BN) cells, which
are the cells that express MNi [21]. Micronuclei (MNi) result from acentric chromosome frag-
ments or whole chromosomes lagging behind during anaphase. Radiation-induced micronu-
clei in peripheral blood lymphocytes (PBLs) strongly correlate with dose and radiation quality.
With a half-life of about a year, micronucleus formation is a proven long-term biomarker for
the evaluation of in vivo radiation exposure of occupationally, medically and accidentally
exposed individuals [23].
Gene expression studies following radiation in human blood [24–26], mice [27–29] and
NHPs [30–32]; are a well-established approach for understanding the mechanism and regula-
tion of the radiation response. In addition, transcriptomic studies have been useful in identify-
ing candidate targets for radiation biodosimetry, using biofluids such as blood and serum
across species [24, 33, 34] and using different modes and types of radiation. We were interested
in the long-term cytogenetic and gene expression response of blood cells to radiation in a large
animal model after partial body irradiation. Therefore, we investigated changes in micronu-
cleus frequency and transcriptomic changes after 10 Gy to the NHP whole thorax. Measure-
ment of MNi yields in the blood lymphocytes after initial radiation exposure showed a
significant induction of MNi that persisted with a gradual decline over the 8-month study
period. Gene expression changes at 2, 5 and 30 days post-radiation showed that although indi-
vidual genes responded differently over the 30-day time course, biological processes and func-
tion enrichment analysis suggested a persistent alteration of the immune system, specifically in
processes related to fighting infection. This is the first study to report the cytogenetic damage
and transcriptomic changes in blood cells following partial body irradiation in NHP using the
Whole Thorax Lung Irradiation (WTLI) model, and the results will be helpful to understand




Nine male Rhesus macaques (Macaca mulatta) of Chinese genetic origin, aged 3.75 to 9.25
years (mean age = 5.59 years) and ranging from 4.2 to 10.3 kg in weight (mean weight = 6.51
kg) were sourced from Primate Products (Immokalee, FL) for this study. All procedures in this
study were performed at Wake Forest University, in accordance with the recommendations in
the Animal Welfare Act and the Guide for the Care and Use of Laboratory Animals of the
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National Institutes of Health [35]. The protocol was approved by the Association for Assess-
ment and Accreditation of Laboratory Animal Care and approved by the Wake Forest Univer-
sity Institutional Animal Care and Use Committee (Animal Welfare Assurance Number A-
3391-01). All efforts were made to minimize suffering. Animals were housed with visual and
limited physical contact with other monkeys, and were fed a diet mimicking the North Ameri-
can Diet (5LOP, LabDiet, St. Louis, MO) with the addition of fruit and vegetables and a variety
of environmental enrichments on a daily basis. These animals were part of a larger study on
the mitigation of radiation-induced lung injury. We obtained samples at pre- and post-irradia-
tion times for our study on radiation induced gene expression and cytogenetic changes in
blood. Animals reaching pre-determined humane endpoints (respiratory rate> 100 breaths
per min) were humanely euthanized by sedation (ketamine, 15 mg/kg) followed by anesthesia
to a deep surgical plane by intravenous pentobarbital (to effect, typically > 30 mg/kg), followed
by exsanguination. Complete necropsy examinations with histopathologic examinations were
done for all animals.
A clinical linear accelerator, calibrated according to national standards for human radiation
treatment, was used for all irradiations. A 6 MV x-ray, two-field, parallel-opposed, isocentric
technique was used with anterior (AP) and posterior (PA) fields. Each oblong field (13.0 cm
long (4.0 cm, 9.0 cm) x 12.0 cm wide) covered the lungs from the superior aspect to 4 cm infe-
rior to the xyphoid and laterally with 2 cm of flash beyond the right and left skin surfaces.
Average AP-PA diameters for 3 groups (sizes) of animals were used to calculate the amount of
beam time in monitor units (MU), and a physical wedge was used in the AP field (heel supe-
rior; angle of 10 to 30 degrees, determined for each animal) as a missing tissue compensator
for improved dose homogeneity at the mid-plane. Dose calculations were performed for
homogenous (water-equivalent) tissue based on the AP-PA diameters, without tissue heteroge-
neity considerations. The fields were equally weighted to deliver 5 Gy each to the AP-PA mid-
line for a total of 10 Gy, with a nominal dose rate typically used for human radiation treatment
of 6 Gy/min (600 MU/min) at the isocenter.
Each NHP was anesthetized with ketamine (5–15 mg/kg, subcutaneously) and dexmede-
tomidine (0.0075–0.015 mg/kg, subcutaneously) and was breathing ambient air. The anes-
thetized animal was placed in the irradiation position on the flat linear accelerator table,
arms up over the head, lightly restrained, with the central axis of the anterior field at the
level of the xyphoid. The AP field was then imaged to confirm position (6 MV x-ray beam
with electronic portal imaging device (EPID)) followed by the same imaging to confirm
position for the opposed, PA field. The PA field was then irradiated (5 Gy) and the linear
accelerator rotated back 180 degrees for irradiation of the AP field (5 Gy). The irradiation
procedure, including animal positioning, portal imaging and irradiation took approximately
18 minutes per animal, with an irradiation time of approximately 3 minutes (PA: 1 min; AP:
2 min).
Respiratory rates were measured daily by cage-side observation of awake animals. Animals
were assessed at least twice daily for evidence of respiratory distress. Whenever animals were
sedated, continuous monitoring of heart and respiratory rates and SpO2 by pulse oximetry
were done. Data were collected from non-sedated animals observed in their home enclosure.
Animals were euthanized when the respiratory rate increased to more than 100 breaths per
minute. Antibiotics and steroids were not administered as part of treatment for these animals.
Animals received supportive care, subcutaneous fluids and non-inflammatories (ketoprofen
3–5 mg/kg buprenorphine 0.01 mg/kg IM) as needed based on pain scores and clinical
pathology.
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Blood collection and counts
Peripheral blood samples (~ 1 mL) were collected in lithium-heparin vacutainer tubes (Bec-
ton-Dickson, Franklin Lakes, New Jersey) and PAXgene RNA stabilization tubes (PreAnalytix,
Qiagen, catalog number 762165). For the micronucleus assay, blood was collected over the
8-month study period (Days -3, 2, 5, 37, 66, 93, 123, 151, 186 and 249). Fresh blood samples
were shipped FedEx priority overnight at ambient temperature to the Center for Radiological
Research, Columbia University Medical Center, New York, NY. During the winter months, a
heat pack was included with the blood shipment. Blood differentials were measured from sepa-
rate EDTA tubes (Becton-Dickinson) collected pre-irradiation (at 191 and 72 days before irra-
diation), and again at 9 days post-irradiation, and then approximately weekly from this time
point until 4 months post-irradiation, at which time blood counts were measured once a
month until 8 months. Total and differential blood counts were done by a veterinary reference
laboratory (IDEXX, North Grafton, MA). Analyses of blood cell counts were performed by
using the Dunnett’s method to adjust for comparison of all times to the baseline.
Micronucleus assay
Whole blood samples (~ 1 mL) were diluted with 5 mL of RPMI-1640 medium (Invitrogen,
Eugene, OR). The diluted blood mixtures were layered over an equal volume of lymphocyte
separation media (Histopaque-1083; Invitrogen); then centrifuged at 1300 rpm for 30 minutes.
The lymphocytes formed at the interface between the separation medium were collected using
a glass pipette and then washed with 1 X phosphate buffered saline (PBS). The cells were trans-
ferred to 12-well multi-well tissue culture plates (Becton, Dickinson and Company, Franklin
Lakes, NJ) containing 5 mL pre-warmed RPMI-1640 medium supplemented with 15% heat-
inactivated fetal calf serum (Invitrogen), 2% Pen/Strep (10,000 units/mL penicillin and
10,000 μg/mL streptomycin; Invitrogen) and 2% phytohaemagglutinin (PHA; Invitrogen).
Cells were cultured at 37˚C in a humidified atmosphere with 5% CO2. After 44 hours of
incubation, cytochalasin B (Cyt-B, catalog number C6762, Sigma; stock solution 3000 μg/mL
dissolved in dimethylsulphoxide; Sigma, St. Louis, MO) was added to the culture medium at a
final concentration of 6 μg/mL. Cells were cultured for an additional 26 hours to arrest cytoki-
nesis and induce the formation of once-divided bi-nucleated cells. To harvest lymphocytes,
samples were transferred to a 15 mL tube and centrifuged at 1,000 rpm for 10 minutes and the
supernatant discarded. The pelleted cells in the tube were treated for 10 minutes with cold
hypotonic solution (0.075 M KCl, Sigma-Aldrich, St. Louis, MO) and fixed twice with ice-cold
fixative (methanol: glacial acetic acid:: 3:1) and then stored at 4˚C in a fireproof refrigerator.
Prior to slide preparation, the lymphocytes were centrifuged, supernatant discarded and resus-
pended in ~0.5 mL of fresh fixative. A small drop of lymphocyte suspension was transferred to
a clean glass slide; then allowed to air dry for 10 minutes. The nuclei were counter-stained
with DAPI Vectashield1 mounting medium (catalog number H-1200; Vector Laboratories,
Inc., Burlingame, CA). The pre-irradiation blood sample from animal NHP 001 was not col-
lected for the CBMN assay.
Scoring and analysis of MNi
The scoring of micronuclei per bi-nucleate (MNi/BN) cell yields was based on the Fenech scor-
ing criteria [36]. MNi/BN yields were evaluated using a fluorescent microscope (Zeiss Axio-
plan 2; Carl Zeiss MicroImaging Inc., Thornwood, NY) with a 40x air objective. At least 500–
1000 bi-nucleated cells were scored per sample, unless indicated otherwise.
WTLI in NHP induces persistent changes in blood
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Statistics
Blood count data were compared over time using a mixed model ANOVA model with a fixed
effect for days since irradiation and a random subject effect. As well estimating a main effect
for time, all post-irradiation time points were compared to the baseline value; p-values were
adjusted for multiple comparisons using Dunnett’s method. A two-sided alpha level of 0.05
was used to indicate statistical significance. All analyses of blood count data were performed in
SAS (v. 9.4, Cary, NC).
For micronuclei data analyses, uncertainties (95% confidence intervals, CIs) for the frac-
tions of bi-nucleated cells with1 micronuclei observed for each NHP donor at each time
after irradiation were calculated using the score confidence interval approach for Binomial
proportions [37]. Logistic regression was used to model the dependence of the fraction of cells
with micronuclei on time, radiation, and NHP donor. The regression was performed using R
software (version 3.2.3). A two-sided alpha level of 0.05 was used to indicate statistical signifi-
cance. We considered the following four model structures, arranged in order of increasing
complexity: (1) pooling the data from all NHP donors and therefore allowing the fraction of
cells with micronuclei to depend only on time and radiation. (2) Allowing the baseline pre-
irradiation fractions of cells with micronuclei (determined by regression intercepts) to vary by
NHP donor, while keeping the effects of time and radiation in common for all animals. (3)
Allowing the baseline levels and the effects of time and radiation to vary by NHP. (4) Adding
quadratic and interaction terms for time and radiation. Data support for these different model
versions were compared using the Akaike information criterion (AIC).
Microarrays, gene ontology and network analysis
Pre-irradiation (3 days before irradiation) and post-irradiation (at 2, 5 and 30 days) whole
blood samples were drawn into PAXgene RNA stabilization solution from 8 NHP exposed to
10 Gy X-rays to the thoracic region in the no-mitigator arm of the larger study. We isolated
RNA from the blood using the PAXgene Blood RNA method (catalog number 762165,
PreAnalytix GmBH), and then depleted globin transcripts using the Ambion GLOBINclear-
Human kit (catalog number AM1980,Life Technologies, Grand Island, NY). We evaluated
the samples for RNA integrity using the Agilent 2100 Bioanalyzer and samples with RIN
values> 8.0 were used for further analysis.
We processed five samples from each of the following groups: pre-irradiation, day 2, day 5
and day 30 and used the RNA for microarray hybridization. We chose five biological replicates
for gene expression analyses and all changes after irradiation were compared with matched
controls; with only one exception where materials were not of the required quantity and total
RNA from two different animals were pooled. We used Agilent Whole Human Genome
4X44K v2 microarrays for measurement of levels of transcripts, following the Agilent recom-
mended protocol. Previous studies have shown the usefulness of human microarray platforms
for the detection of NHP gene expression [30, 38, 39]. We then used the class comparison tool
in BRB Array Tools [40] using a p-value cut-off of 0.005 and False Discovery Rate (FDR)
<10% to identify differentially expressed genes between groups. The data are deposited in the
Gene Expression Omnibus database as GSE84898.
We further analyzed the differentially expressed genes at each time in this study using the
PANTHER ver 10.0 (Protein ANalysis THrough Evolutionary Relationships) gene ontology
tool [41]. Benjamini corrected p-values <0.05 were considered significant. Genes that were
significantly differentially expressed from each time point were also imported into Ingenuity
Pathway Analysis (IPA from Ingenuity1 Systems, http://www.ingenuity.com) software. In this
analysis software, we used the core gene-expression analysis tool to predict networks and
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associations between genes and regulatory molecules based on curated information from pub-
lished data. We focused our analysis on RNA, proteins and genes as potential upstream regula-
tors with predicted involvement in the gene expression networks. IPA calculates a z score for
each upstream regulator based on the number of target genes in the gene list and the type of
relationship (transcriptional activation or inhibition) between the regulatory molecule and the
downstream transcripts [42]. The z score is a significance measure that a regulator may be
involved in gene regulation based on published literature and also indicates the activation
state of a regulator. We compiled a list of transcriptional regulators with z scores of absolute
value 2 for at least one time point in the time course, indicating significant activation/inhibi-
tion for at least one time point. For the 82 regulators that passed this criteria, we also included
intermediate z scores (-2> z score < 2) at other time points for analysis. An intermediate z
score (-2> z score< 2) suggests that there were gene targets within the data set downstream
of the transcriptional regulator, and that the prediction was directional, but a proportion of
the regulator-target relationships were inconsistent with findings in the literature. A transcrip-
tional regulator that was not involved in upstream regulation was not assigned a z score.
qRT-PCR measurement of mRNA levels and analysis
We prepared complimentary DNA (cDNA) from total mRNA using the High-Capacity cDNA
Archive Kit (Life Technologies, Foster City, CA). Quantitative real-time RT-PCR (qRT-PCR)
was performed for selected genes using Taqman1 assays (Life Technologies) to confirm
microarray experiment findings for the selected genes. Assays used were: IL1R1 (assay ID:
Rh00991008_m1), LY96 (assay ID: Rh01026731_m1, MARCKSL1 (assay ID: Hs00702769_s1)
and FAIM3 (assay ID: Rh02857660_m1). 30 ng of cDNA was used as input in duplicate reac-
tions. Quantitative real time PCR reactions were performed with the ABI 7900 Real Time PCR
System using Universal PCR Master Mix (Thermofisher), with initial activation at 50˚C for
120 seconds and 95˚C for 10 minutes, followed by 40 cycles of 95˚C for 15 seconds and 60˚C
for 60 seconds. Relative fold-induction was calculated by the -ΔΔCT method [43], using SDS
version 2.4 (Thermofisher). Data were normalized to GAPDH (assay ID: Rh02621745_g1)
gene expression levels, which were found to be stably expressed across all samples.
Results
Blood counts
Initially, lymphocyte and platelet counts declined significantly, approximately 30% from base-
line by day 9 post-irradiation (p-values < 0.05), see Fig 1B and 1C. These measurements
returned to base line within 24 days, by which time the mean neutrophil count had doubled
(Fig 1D), rising to a 3-fold mean increase by day 66, (p-value < 0.05 for both), and corre-
sponding to the expected pattern of radiation-induced pneumonitis. A third significant peak
of neutrophilia occurred at 185 days post-exposure, disappearing by the study’s end at day 250.
Animals that were euthanized later for elevated respiratory rates had higher neutrophil counts
during the first 50 days of the study.
Micronucleus assay
Frequencies of micronuclei (MNi) were evaluated using the in vitro cytokinesis-block micro-
nucleus (CBMN) assay and micronucleus yields per bi-nucleate cell (MNi/BN) were scored.
Table 1 shows MNi frequency as the fraction of BN cells with one or more micronuclei for
each NHP animal at specific time points up to 8 months after irradiation to the whole thorax.
Blood samples where it was difficult to score more than 500 binucleate cells () and blood
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cultures () that showed no apparent mitogen-induced cell division are indicated. Four NHPs
were sacrificed before the end of the study, NHP 002 (day 69), NHP 007 (day 57), NHP 008
(day 57) and NHP 009 (day 94); the trigger for euthanasia was an increase in respiratory rate
to more than 100 breaths per minute. Overall, qualitative observations of the DAPI-labeled
cells indicated an increased number of apoptotic and non-divided cells after radiation
exposure.
Best-supported regression results based on AIC (Fig 2, Table 2) showed a strongly statisti-
cally significant increase in the fraction of cells with micronuclei after irradiation, which
declined over time; and evidence for variation in baseline micronucleus frequencies between
the NHPs. This model produced a reasonable fit to the data. Inclusion of possible donor-
dependent variations in the effects of time and/or radiation, quadratic terms for time and/or
radiation, or interaction terms between them, were not statistically supported based on the
AIC. The results also highlight that for the surviving animals, NHP 004, NHP 005 and NHP
006; the MNi frequency remained above baseline.
Fig 1. Differential blood cell counts. Total leukocyte counts (A) were most elevated at 66 days, reflecting neutrophilia (D). Transient reductions of lymphocyte
counts (B) and platelets (C) were seen at day 9. Day 0 values are the overall average and SEM of the day -72 baseline measurements.  = significantly different
from baseline at p<0.05 using Dunnett’s method. Error bars are 1 standard error of the mean.
https://doi.org/10.1371/journal.pone.0191402.g001
WTLI in NHP induces persistent changes in blood
PLOS ONE | https://doi.org/10.1371/journal.pone.0191402 January 19, 2018 8 / 24
Fig 3 shows the results from a pooled analysis for all the animals over the duration of
the study. These data show similar effects of radiation and time to Fig 2. Further, the results
show that the fraction of binucleated cells with micronuclei significantly increased (p-value <
0.05) after the acute 10 Gy dose followed by a slow decline up to 8 months after WTLI. As
expected, the fit quality of the pooled analysis was somewhat worse than the individual analy-
ses because the variations in baseline MNi frequencies were not accounted for. Pooled analysis,
assuming no variability in the baseline MNi frequencies between animals, showed that there
was a statistically significant elevation in MNi frequency even at day 249 (compared to day 0;
p-value = 5.2 X 10−3, Pearson’s Chi-square with Yate’s correction)
Microarray results and gene ontology analysis
Analysis using the Agilent Whole Human Genome microarray platform showed that 1187
genes were affected in blood cells over the course of the study. Class comparisons were paired
by animal, and 545, 273 and 603 genes were found to be significantly differentially expressed
(p-value < 0.005 and FDR< 10%) at the mRNA level on 2, 5 and 30 days, respectively (S1
Table). A trend of increasing proportion of down-regulated genes was observed, with 20%,
32% and 57% of the differentially expressed genes down regulated at 2, 5 and 30 days, respec-
tively. Overlap between the responding genes at various time points is shown in Fig 4 as a
Venn diagram (also see S1 Table).
We looked for biological processes that were significantly overrepresented among the dif-
ferentially expressed genes at the various time points using the PANTHER gene ontology pro-
gram [41, 44]. We found that although more genes were differentially expressed at 30 days
(603 genes) than at day 2 (545 genes), there were more biological processes significantly
enriched (Bonferroni p-value 0.05) among the genes at 2 days than those at 30 days, see
Table 3. Further comparisons showed that although there were only 81 differentially expressed
genes common to days 2 and 30 (Fig 4), all biological processes enriched in changed genes at
30 days were also significantly over represented among those at 2 days (Table 3). Common
processes that appeared to be affected throughout the time course were immune system and
single organism signaling related to infection. Bacterial response and oxygen containing com-
pounds were significant at 2 days and 30 days after irradiation, but not at 5 days.
Table 1. Micronucleus frequency in NHP peripheral blood lymphocytes measured up to 249 days post exposure.
MNi frequency
Day -72 2 5 37 66 93 123 151 186 249
NHP 001 -- 0.066 0.060 0.049 0.065 0.055 0.067 0.058 0.056 0.067
NHP 002 0.033 0.049 0.053 0.050  SAC
NHP 003 0.038 0.062 0.063 0.062 0.061 0.066 0.052 0.067 0.061 0.058
NHP 004 0.041 0.058 0.091 0.080 0.048 0.049 0.060 0.057 0.053 0.058
NHP 005 0.063 0.084 0.063 0.086 0.086 0.055 0.072 0.064 0.067 0.060
NHP 006 0.053 0.090 0.087 0.084 0.066 0.080 0.060 0.071 0.054 0.048
NHP 007 0.055 0.059 0.067 0.062 SAC
NHP 008 0.039  0.071 0.061 SAC
NHP 009 0.024 0.073 0.060 0.076 0.056 0.045 SAC
indicates that fewer than 500 bi-nucleated cells were scored
 indicates limited cell growth in the cell cultures
SAC denotes NHP sacrifice time.
https://doi.org/10.1371/journal.pone.0191402.t001
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The PANTHER gene ontology analysis of the gene expression response in blood cells at the
earliest 2-day time point revealed a highly structured and cohesive response to irradiation of
the thorax. Biological functions affected at this early time point appeared to reflect a concerted
response of the immune system involving activation of almost every blood cell type: platelet,
leukocyte, myeloid leukocyte and macrophage activation. Blood coagulation and response to
wounding, chemotaxis and leukocyte migration were other processes significant only at 2 days
Fig 2. Micronucleus frequency of individual animals. Logistic regression analysis of the fractions of binucleated cells with micronuclei at various times after
irradiation across different NHPs. Error bars are 95% confidence intervals.
https://doi.org/10.1371/journal.pone.0191402.g002
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(Table 4) and not at other time points. Child term categories of biological functions such as
defense response to Gram-positive bacterium and regulation of tumor-necrosis superfamily
production were also observed, suggesting the early activation of specific damage and infection
response signaling pathways in blood cells following thoracic irradiation.
Table 2. Best-fit logistic regression parameter estimates for the fraction of cells with micronuclei.
Variable Parameter estimate Standard error p-value
Time (days) -0.0011 0.0003 2.21×10−4
Radiation (Indicator) 0.4579 0.0715 1.48×10−10
NHP 001 (Intercept) -3.1036 0.0896 2.00×10−16
NHP 002 -0.2598 0.1151 0.0239
NHP 003 0.0202 0.0747 0.7867
NHP 004 0.0499 0.0795 0.5305
NHP 005 0.1841 0.0771 0.0170
NHP 006 0.1978 0.0740 0.0075
NHP 007 0.0520 0.1123 0.6432
NHP 008 -0.0032 0.1125 0.9773
NHP 009 -0.1344 0.1129 0.2339
https://doi.org/10.1371/journal.pone.0191402.t002
Fig 3. Micronucleus frequency of animals (pooled samples). Mean micronucleus frequency from lymphocytes of
nine irradiated NHPs, up to 8 months after WTLI. The error bars are 95% confidence intervals.
https://doi.org/10.1371/journal.pone.0191402.g003
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Fig 4. Venn diagram of differentially expressed genes. Differentially expressed genes in blood at 2, 5 and 30 days
after WTLI in NHP are shown in the Venn diagram. 25 genes were significantly differentially expressed at all the time
points in the study.
https://doi.org/10.1371/journal.pone.0191402.g004
Table 3. PANTHER Gene ontology analysis of biological processes. Processes that were significantly enriched in
differentially regulated genes at a minimum of two time points in the time course.
GO biological process complete Day 2 Day 5 Day 30
p-value p-value p-value
immune system process 5.33 X10-31 1.02 X10-8 1.41 X10-3
response to stimulus 3.12 X10-26 1.52 X10-5 1.27 X10-3
single organism signaling 2.92 X10-17 1.46 X10-2 1.74 X10-4
defense response 1.99 X10-23 5.14 X10-6 NS
response to stress 1.82 X10-21 4.89 X10-4 NS
immune response 1.99 X10-19 3.16 X10-6 NS
response to molecule of bacterial origin 7.30 X10-11 NS 4.45 X10-2
response to oxygen-containing compound 1.79 X10-9 NS 4.73 X10-2
All p-values are Bonferroni corrected for multiple testing, NS: not significant
https://doi.org/10.1371/journal.pone.0191402.t003
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Network analysis
Network analysis using IPA revealed a shifting landscape of functional changes across the time
course with a few common processes and regulators being involved at all times. We used IPA
to predict candidate upstream regulators of the gene expression changes observed and com-
pared their activation/inhibition states at the different post-irradiation times (Fig 5 and S2
Table). We identified 82 candidate regulatory molecules that showed a z score absolute value
of at least 2 at a minimum of one time-point in the study. To look at trends in behavior of
these transcriptional regulators we also included other time points where the z scores were
-2< z score < 2. This approach allowed us to get an overview of potential changes in gene reg-
ulation across the time course, which provide candidate target molecules for future studies,
where we may have access to intermediate time point samples and proteins. We classified
these 82 regulators into three groups (S2 Table) based on their predicted status at specific
Table 4. PANTHER biological processes related to the immune response, which are significant at 2 days after
WTLI and not significant at later time points.
GO biological process complete Day 2
p-value
cell communication 3.20 X 10−18
signal transduction 1.60 X 10−17
cell surface receptor signaling pathway 2.57 X 10−16
inflammatory response 1.77 X 10−14
cell activation 4.42 X 10−12
response to bacterium 5.69 X 10−12
response to lipopolysaccharide 5.94 X 10−10
innate immune response 1.85 X 10−9
regulation of tumor necrosis factor superfamily production 2.42 X 10−9
blood coagulation 3.78 X 10−9
response to wounding 8.12 X 10−9
regulation of cytokine production 2.21 X 10−8
regulation of body fluid levels 2.22 X 10−7
platelet activation 6.35 X 10−7
leukocyte migration 7.10 X 10−7
regulation of leukocyte activation 8.14 X 10−7
platelet degranulation 1.81 X 10−6
regulation of programmed cell death 3.81 X 10−6
regulation of lymphocyte activation 7.31 X 10−6
negative regulation of mononuclear cell proliferation 5.19 X 10−5
secretion by cell 8.76 X 10−5
leukocyte activation 9.07 X 10−5
chemotaxis 1.29 X 10−4
defense response to Gram-positive bacterium 2.83 X 10−4
myeloid leukocyte activation 5.52 X 10−4
endocytosis 6.06 X 10−4
cell adhesion 8.61 X 10−4
exocytosis 1.13 X 10−3
cell migration 1.25 X 10−3
macrophage activation 2.10 X 10−3
All p-values are Bonferroni corrected for multiple testing
https://doi.org/10.1371/journal.pone.0191402.t004
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Fig 5. IPA prediction of regulatory molecules. We grouped by these molecule by pattern using the upstream
regulator option in IPA and comparing all time-points in the study, which revealed three types of upstream regulators.
A. Group 1, with persistent activation/inhibition states across the study; B. Group 2, regulators that show a trend from
activated to inhibited during the course of the study; and Group 3, only activated at one time-point (see S2 Table). All
regulators shown pass the z score cut-off absolute value 2 for at least one time point in the study.
https://doi.org/10.1371/journal.pone.0191402.g005
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times in the study. Group 1 consisted of regulators predicted to be consistently either activated
or inhibited at all time-points measured (Fig 5A); Group 2 was defined by a potential change
in activity across the time course (Fig 5B); and Group 3 included regulators only predicted to
be activated or inhibited at one of the surveyed times (S2 Table).
Most of the 21 candidate regulators in Group 1 have known roles in radiation response. In
Group 1, which were predicted to be consistently activated/inhibited, TNF (tumor necrosis
factor alpha), TGM2 (Transglutaminase 2), IKBKB (inhibitor of kappa light polypeptide gene
enhancer in B-cells, kinase beta), HIF1A (hypoxia inducible factor-1A), P38-MAPK (p38
MAP kinase) and cytokines IL5 (Interleukin- 5), IL6 (Interleukin-6) are included, all of which
have a known role in radiation or immune response. The microRNA miR-223, which is a
known regulator of erythroid blood cell development [45], was also predicted as activated with
a z score greater than 2 across the time course. The persistently inhibited regulatory factors in
Group 1 included DUSP1 (Dual specificity phosphate 1), ER (Estrogen receptor) and Ig
(Immunoglobulin) (Fig 5A). Group 2, with 13 members, was the smallest group of candidate
regulatory molecules. TGFB1 and TGFB2 (Transforming growth factors beta 1 and 2), IFNG
(Interferon gamma), STAT3 (signal transducer and activator of transcription 3,) and PGR
(progesterone receptor) are members of this group with IFNG and PGR predicted to be acti-
vated at 2 days after WTLI, then inhibited at the intermediate 5 day time-point; and then
returning to activation again at 30 days. Group 3 consisted of regulatory molecules only acti-
vated/inhibited at one time-point in the time course, suggesting that these specific regulatory
molecules may be more time-specific in response to radiation in NHP blood cells. The mem-
bers of this group are listed in S2 Table.
Discussion
NHP have been used in radiation dose response studies for many decades [9–11, 17, 46], focus-
ing on the effects of mitigators on acute radiation syndromes of different organ systems and
mortality. However, there have been few studies of the cellular and molecular level changes
underlying these broad biological end-points. Recently, a few studies have begun to explore
the effects of blood cell loss and recovery over time [12] and the transcriptomic response in
blood to viral infection [47].
In our study, we used the WTLI model of thoracic irradiation above the midline in NHP,
and focused on long-term effects (up to 8 months for micronucleus frequency and up to 30
days for transcriptomics) in blood cells. In a recent retrospective dose-reconstruction study,
Prado et al [18] calculated that the mean lung and heart dose averaged across 80 NHPs result-
ing from an average WTLI dose of 10 Gy would be 11.05 Gy and 10.8 Gy, respectively. Since
blood flows through the lungs at 2–5 liter minute-1 [48], a 10–15 minute lung irradiation pro-
tocol will result in uniform irradiation to the blood in M. mulatta [49]. For our dose and
shorter duration of irradiation, we estimate that the dose to the entire blood pool is approxi-
mately 10–20% of the dose delivered to the midplane. After the acute dose exposure, irradiated
cells would be mixed with newly divided unexposed blood cells over the time course, providing
a relevant example of an irradiation scenario that might occur in a radiological event.
Our hematology results show a similar pattern compared to the PBI/BM5 model, where
transient decreases in lymphocyte count and platelet count were seen, to a lesser degree than
in TBI (11). Our findings with WTLI show a reduced but still-present lymphopenia and
thrombocytopenia early on, but differ from the PBI/BM5 model in that a profound neutrophi-
lia is seen approximately 2 months after irradiation, presumably reflecting the response by a
largely spared bone marrow pool to radiation-induced pulmonary injury.
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To evaluate long-term DNA damage response in the NHP lymphocytes, we used the estab-
lished human CBMN assay protocol to determine MNi frequency in blood lymphocyte sam-
ples collected up to 8 months after initial whole thorax irradiation (Table 1 and Fig 2).
Regression analysis showed a significant induction of MNi in the blood lymphocytes across all
nine NHPs that persisted with a gradual decline over the 8-month study period, indicating
long-term DNA damage in the blood lymphocytes after WTLI (Fig 3). The slow decline in
MNi frequency over time may be attributed to the replenishment of mature lymphocytes from
damaged and non-damaged progenitor cells in the bone marrow. At 8 months post exposure,
we show that MNi frequency remained above baseline. These results are encouraging for the
utility of the MNi biomarker in a partial body, long-term animal model. Previously, Gregoire
et al reported elevated translocation and dicentric chromosome frequencies in blood samples
from total body gamma ray irradiated NHPs up to 31 months after irradiation [50] and Thie-
rens et al were able to derive dose estimates from dicentrics chromosomes and micronucleus
frequencies 6 months after an accidental exposure of a radiological worker [51].
Few studies have used the NHP animal model for cytogenetic biodosimetry. For cytogenetic
analyses, the challenge lies in using an optimal culture medium and mitogen where first-divi-
sion cells are preferred [8]. In the present work, we struggled to score sufficient binucleated
(BN) cells in the blood samples collected during the first week post exposure, particularly at 2
days after WTLI (Table 1). These blood samples are likely to include a large proportion of
highly damaged mature peripheral blood lymphocytes, which were apoptotic and/or have
undergone cell-cycle arrest. The relative MNi yields measured at days 2 and 5 indicate also
that the PHA mitogen favored the stimulation of the less damaged lymphocyte cells over the
highly damaged cells in the blood cultures. The precipitous drop in lymphocyte numbers by 9
days supports the notion that a large proportion of the circulating lymphocytes had initiated
radiation-induced apoptosis and cell death rapidly shortly after WTLI exposure. In the context
of a radiological incident or accident where many individuals could receive an acute high-dose
partial body exposure of ionizing radiation, future work should look to optimize the CBMN
assay culture conditions for increased/improved mitogen-induced cell division of heavily dam-
aged NHP lymphocyte cells.
The blood cells collected from the WTLI irradiated NHPs revealed an overall gene expres-
sion response enriched in processes that modulate the immune/inflammatory response to
damage and infection, with variations in response at different times. The 2-day response, with
545 genes changing and many biological processes implicated, appeared to be the most dra-
matic within this time course. At day 2 specifically, processes suggesting blood cell loss, such as
negative regulation of mononuclear cell proliferation (p-value = 10−5) and platelet activation/
degranulation (p-value = 10−6) were implicated within both up and down regulated genes.
However, at 30 days there were even more responding genes (603 genes, Fig 4), but the biologi-
cal functions involved at this time were limited to a subset of those at earlier times (Table 3).
This suggests that renewal of cells and recovery of normal biological processes and cell num-
bers may have occurred by 30 days after WTLI. However the immune system remains in a
heightened state long after the initial exposure, as suggested by gene expression changes in bio-
logical categories related to immune responses (p-values 10−31 at 2 days and 10−4 at 30 days)
and bacterial response (p-values 10−11 at 2 days and 10−2 at 30 days).
The persistent effect of radiation on transcription in blood cells is seen by examining genes
that were significantly differentially expressed at all times in the study. There were 25 such
genes, all of which changed in the same direction; either up or down regulated, throughout the
study (Fig 6). The up regulated genes contributing to immune response such as IL1R1 (Inter-
leukin 1 receptor, type 1) (43) and TLR6 (Toll-like receptor 6) [52, 53], again suggest a persis-
tent alteration of immune response occurring over the course of the 30-day study. This is
WTLI in NHP induces persistent changes in blood
PLOS ONE | https://doi.org/10.1371/journal.pone.0191402 January 19, 2018 16 / 24
consistent with previous studies on GI-ARS and H-ARS in NHP where radiation effects were
observed on blood cell counts for neutrophils, lymphocytes and platelets, within the first week
after TBI [11]; and from PBI/BM5 studies on NHPs in which neutropenia and thrombocytope-
nia occurred within the first 11 days after irradiation [17]. Further studies on earlier (1 day
after irradiation) and intermediate time points such as 7 and 14 days after irradiation, would
help to determine if these gene expression and cellular changes fluctuate at intermediate time
points, or maintain a steady induction/inhibition level in the 30-day time period as generally
appears from the present data.
We validated changes in levels of mRNA for two up and two down regulated genes as mea-
sured by microarrays (Fig 6), using real-time qRT-PCR (Fig 7). The genes we measured were
IL1R and LY96 (Lymphocyte antigen 96/Myeloid differentiation factor 2), which were consis-
tently up regulated after irradiation; and MARCKSL1 (Myristoylated alanine-rich C kinase
substrate-like 1) and FAIM3 (Fc fragment of IgM receptor), which were down regulated after
irradiation. We found that measurements using PCR closely correlated with microarray fold
changes for most time points and genes measured.
Using a network approach, we identified several strong candidate regulators of the tran-
scriptional changes observed over the 30-day time course (Fig 5). Information of networks and
signaling pathways based on gene expression changes could facilitate the understanding of the
nature of the biological response to radiation and the changes over time. We grouped the
Fig 6. Microarray results of gene expression changes of 25 genes, common across all time points. Gene expression changes of the 25 genes that were
differentially expressed at all the time points assayed, the intersection of all groups taken from Fig 4. These genes were selected based on being significantly
changed at all times in the study. In each comparison, gene expression signal intensities of these 25 genes at days 2, 5 and 30 were compared with the pre-
exposure levels in the matched control to determine fold changes, the bars in the histogram are the mean fold change in five independent biological
replicates, error bars are SEM. The dashed line represents the normalized pre-exposure expression level.
https://doi.org/10.1371/journal.pone.0191402.g006
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potential regulators into three categories based on patterns of response. Group 1 included pre-
dicted upstream regulators with consistent activation/inhibition states at all the time points in
this study. This group includes transcriptional regulators such as transglutaminase 2 (TGM2),
an enzyme that leads to activation of transcription factors NFκB and HIF1β through a transa-
midation reaction [54], and which is involved in cell fate of blood cells [55, 56]. This is a novel
regulator in ionizing radiation response in blood cells. Also in Group 1 were well-known radi-
ation response regulators such as TNF proteins, interleukins (IL1B, IL5 and IL6) and hypoxia
response regulator HIF1A [57–59]. IKBKB (which is a negative regulator of NFkB) and
p38MAPK; were also predicted to be activated and may have a role in the radiation response
Fig 7. qRT-PCR validation of gene expression changes. Gene expression was measured in blood cell RNA using qRT-PCR to validate the microarray
measurements. Two consistently up regulated genes are shown here, IL1R1 (A) and LY96 (B); and two downregulated genes, MARCKSL1 (C) and FAIM3
(D). Relative expression are mean fold changes at 2, 5 and 30 days in at least three biological replicates. Microarray changes are solid symbols (●) and
qRT-PCR fold changes are shown in open symbols (o), representing the mean, error bars are SEM.
https://doi.org/10.1371/journal.pone.0191402.g007
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in blood cells [60, 61]. CSF2, also called GM-CSF (granulocyte-macrophage colony stimulating
factor) was in Group 1, as a predicted persistent activator of genes. CSF2 is well known for its
ability to counter myelosuppression [62] and is administered after radiological events to boost
and activate the immune response to infection [63]. Our results indicate that endogenous
CSF2 activation may occur after partial body irradiation. The microRNA miR-223, known to
be involved in red blood cell development via LMO2 (LIM-only protein 2, rhombotin-like 2)
[45] was predicted to lead to both up and down regulation of specific transcripts in the study.
Surprisingly, in our study most potential downstream targets of miR-223 were up regulated at
the mRNA level rather than the expected repression of genes by microRNA mediated silenc-
ing. It is possible that current information about the indirect targets of microRNA miR-223 is
incomplete and that an intermediate transcriptional regulator may be responsible for its poten-
tial role as a transcriptional activator [64, 65].
We also observed another interesting pattern in the prediction of transcriptional regulators,
where the state of the regulator might switch from activated to inhibited, and then back again,
over the time course. Most striking were the predicted responses of IFNG (Interferon G) and
PGR (progesterone receptor), which changed from activated to inhibited and then activated
again at 2, 5 and 30 days after irradiation, respectively (Fig 5B). We also looked for other
known regulators involved in oxidative stress after radiation and NRF2 (NFE2L2, Nuclear Fac-
tor, erythroid 2 like 2) which is a transcription factor that induces gene expression of protective
genes against oxidative stress, and was predicted to be activated at 2 days after irradiation. This
is a central player in cellular defense against xenobiotics and oxidative damage [66] and the
early activation of this transcription factor may indicate high levels of oxidative damage in the
initial response to radiation. Further studies on intermediate time points and complementary
cellular/physiological results could clarify the role of these types of regulators and their role in
the radiation response in blood.
Taken together, our study is an important first step in our understanding of the long-term
cellular and molecular response to partial body irradiation using the NHP WTLI model. The
MNi biomarker showed a robust response to high-dose partial body irradiation and has poten-
tial for cytogenetic biodosimetry studies to estimate absorbed dose weeks after a radiological
incident or accident. Future studies should look to validate this biomarker for long-term retro-
spective dose estimations. The gene expression response in blood cells up to a month after par-
tial body irradiation revealed a combination of persistent and time-point specific changes
indicating that the earliest change (measured in this study) is also the strongest response. The
gene expression changes suggested enrichment of processes related to blood cell loss at 2 days
after exposure. Following this, at 5 days after irradiation, the immune response was persistent
and included specific genes that suggest mechanisms responding to infection and single organ-
ism signaling remain affected. At 30 days after irradiation, changes in immune response genes
appear to be maintained; however, blood cell counts show that non-immune, neutrophil-
mediated responses to tissue injury and possibly bacterial infection predominate, waning as
pulmonary injury progresses from pneumonitis to fibrosis. Further studies are required to elu-
cidate how the biological response evolves over time. The long-term effects of radiation at the
transcriptomic level corroborate the observed physiological changes in blood cells, and could
be useful in identifying potential drug targets for future mitigator studies.
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S1 Table. Significantly differentially regulated genes. Gene lists of differentially expressed
genes at all time-points in the study.
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S2 Table. IPA regulatory factor analysis. Complete list of IPA generated upstream regulators
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